Over the years I've enjoyed reading all of Adam's articles because they are entertaining and thought provoking. I read his most recent Ampio article, I totally agree with him the end of the lock-up period is a factor for any investor to consider, especially traders. The rest of the article is pure entertainment, and pathetic. I e-mailed Adam and asked him why Ampio's compounds are "highly speculative", and what market cap would he give Ampio today? I'm waiting for a reply. Adam knows less about Ampio than he does about writing. Ampio IS DMI. DMI's three lead products are reconstituted compounds previously approved by the FDA for other indications. Not "highly speculative" as Adam states. DMI has patents on at leaast 25 other compounds, not to mention the immense potential for their diagnostic products. The man behind Ampio/DMI is Dr. David Bar-Or, he is brilliant. He has 30 years emergency room experience. He heads two level one trauma centers in the Denver area. Dr. Bar-Or is the real deal and so are Ampio/DMI's compounds and patents. Long term investors (5-10 years out) will thank the day they bought Ampio shares, those who didn't buy will understand Adam is a thought provoking, well paid entertainer.